A fresh perspective on the feline market
Built to help pet care strategy teams understand where feline health investment is actually gaining traction (and where it isn’t).
What’s inside
Published by the team behind Feline Business Brief, the Feline Business Monitor is a quarterly analysis of trends shaping the cat space, including:
- Corporate strategy, M&A and product launches
- Feline therapeutics and diagnostics
- Cat food, nutrition, and premiumisation
- AI-powered smart health trackers
- Consumer behaviour and ownership trends
Built for industry leaders, investors, and strategists who need cat-specific insight, not generic pet coverage.
The feline market gap
The global pet industry is increasingly feline-driven, yet most market coverage still treats cats as a secondary segment.
Feline economics differ fundamentally from dogs across purchasing behaviour, healthcare utilisation, pricing sensitivity, and product design.
As a result, senior decision-makers are often relying on dog-led reports, fragmented news, or vendor-biased research when making cat-related decisions.
How Feline Business Monitor is different
- 100% feline-focused
- Cross-market synthesis
- Independent analysis, not vendor-commissioned or sponsor-led
- Designed for strategic decision-making, not marketing narratives
Headline insights
Cats have moved from a niche concern to a growth driver.
Our key findings point to a structural re-rating of the feline category, from cats being seen as just “small dogs” to becoming a strategic growth pillar. This has direct consequences for portfolio strategy, innovation pipelines, regulatory planning and investment prioritisation.
Feline technology is entering a phase defined by ecosystem control.
AI-enabled device launches in Q4 2025 highlight a shift from convenience hardware to preventive health monitoring, with implications for veterinary integration and data-driven care models.
Investment patterns are bifurcating across the feline category.
Q4 2025 funding activity revealed a widening gap between early-stage, science-led bets in diagnostics and longevity (e.g. The Cat Health Company, MI:RNA), and late-stage capital concentrating around a small number of proven, brand-led nutrition platforms (e.g. KatKin’s US$50m Series C).
Feline therapeutics is entering an acceleration phase after decades of underinvestment.
Recent regulatory approvals and R&D activity suggest a structural shift in how feline treatments are conceived, funded, and commercialised, addressing a longstanding feline care gap. Longevity is emerging as a strategic organising theme.
Germany serves as a bellwether market for European feline dynamics.
With a feline-majority pet population, strong veterinary infrastructure, and steady premiumisation, Germany provides a useful stress-test for whether feline products can scale beyond early adopters and into mainstream European demand.
Report structure
- Executive summary
- Global market snapshot
- Brand moves & funding
- Raises
- Investments
- M&A
- Notable product launches
- Trend deep dives
- Early signals: Accelerating progress in feline therapeutics
- Cat ‘longevity’ theme receives major backing
- Early signals from new feline product launches
- AI-powered preventive cat care is advancing, but through closed loops
- Regional spotlight
- Germany: Europe’s feline stress-test market
- Feline Business Brief Q4 2025 insights
- Signals to watch in Q1 2026t
Who Feline Business Monitor is for
This report is designed for:
- Pet brand executives
- Senior leadership teams and strategy roles
- Founders building cat-focused products and services
- Consultants and advisors working with pet brands
This report may not be for you if:
- You only want high-level market size figures
- You are looking for consumer lifestyle content
- You prefer dog-led or general pet coverage
Format & delivery
- Digital PDF report
- Approx. 35 pages of text, infographics and data
- One-time purchase
- Immediate access upon release (January 15, 2026)
Licensing
- For individual professional use. Not licensed for internal redistribution.
- Team and enterprise licences available for internal circulation. For institutional access, contact team@felinebizbrief.com.
Price & access
Feline Business Monitor (Q1 2026), Individual licence.
GBP 299.00 (VAT not applicable).
FAQs
When will the report be released?
January 15, 2026.
Is this a subscription?
No. Each quarterly Monitor is sold individually.
Can I expense this through my company?
Yes, a Stripe invoice will be provided automatically.
Do you offer team or enterprise access?
Yes. Please contact us at team@felinebizbrief.com for institutional access.